Fujian Green Pine
300132
Yili Chuanning Biotechnology
301301
Shanghai Menon Animal Nutrition Technology
301156
4
Anhui Hyea Aromas
300886
5
Tuoxin Pharmaceutical Group
301089
CN Stock MarketDetailed Quotes
002678 Guangzhou Pearl River Piano Group
- 4.50
- +0.05+1.12%
Market Closed May 15 15:00 CST
6.12BMarket Cap-22.84P/E (TTM)
4.53High4.40Low52.28KlotVolume4.45Open4.45Pre Close23.44MTurnover0.39%Turnover RatioLossP/E (Static)1.36BShares5.8952wk High1.80P/B6.11BFloat Cap3.3252wk Low4.90Limit Up1.36BShs Float22.32Historical High4.01Limit Down2.92%Amplitude2.96Historical Low--Dividend TTM4.48Avg Price21.39KlotAsk--Div YieldTTM100Lot Size30.81KlotBid
Guangzhou Pearl River Piano Group Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -42.11%123.51M | -39.97%677.17M | -41.60%526.96M | -42.65%364.08M | -42.88%213.34M | -32.05%1.13B | -31.47%902.32M | -25.19%634.8M | -22.54%373.49M | -17.82%1.66B |
| Operating revenue | -42.11%123.51M | -39.97%677.17M | -41.60%526.96M | -42.65%364.08M | -42.88%213.34M | -32.05%1.13B | -31.47%902.32M | -25.19%634.8M | -22.54%373.49M | -17.82%1.66B |
| Other operating revenue | ---- | 3.75%68.81M | ---- | 8.96%30.27M | ---- | 128.21%66.32M | ---- | 15.91%27.78M | ---- | -22.90%29.06M |
| Total operating cost | -24.43%176.15M | -24.57%890.99M | -26.59%657.02M | -29.39%428.61M | -31.39%233.09M | -23.78%1.18B | -25.75%895.06M | -21.11%606.99M | -18.12%339.75M | -14.65%1.55B |
| Operating cost | -38.02%111.01M | -32.62%609.36M | -35.69%459.67M | -35.52%313.53M | -35.23%179.1M | -28.30%904.43M | -28.03%714.81M | -22.90%486.27M | -20.15%276.52M | -16.33%1.26B |
| Operating tax surcharges | 2.57%5.47M | 2.41%20.56M | 4.68%15.22M | 0.72%9.41M | 4.70%5.34M | -10.86%20.07M | -13.45%14.54M | -14.38%9.34M | -13.86%5.1M | -12.30%22.52M |
| Operating expense | -9.88%11.48M | -19.41%59.15M | -21.90%42.85M | -38.91%25.25M | -21.84%12.74M | 7.71%73.4M | 21.40%54.87M | 46.41%41.32M | 39.81%16.29M | 2.88%68.15M |
| Administration expense | 44.97%43.12M | 9.62%167.32M | 35.62%117.67M | 20.30%65.89M | 2.81%29.74M | 18.32%152.64M | -13.59%86.76M | -6.79%54.77M | -7.57%28.93M | -10.65%129M |
| Financial expense | 40.07%-3.24M | 74.77%-9.43M | 63.77%-11.33M | 64.09%-7.93M | 42.14%-5.41M | -139.14%-37.38M | -111.58%-31.27M | -317.10%-22.08M | -113.96%-9.34M | 37.94%-15.63M |
| -Interest expense (Financial expense) | -36.59%1.08M | -60.79%6.03M | -57.37%4.83M | -57.57%3.54M | -35.52%1.71M | -21.99%15.38M | -11.04%11.34M | 55.24%8.33M | 191.77%2.65M | 18.60%19.71M |
| -Interest Income (Financial expense) | 38.16%-3.54M | 62.97%-17.98M | 61.68%-15.24M | 61.01%-10.51M | 52.38%-5.72M | -44.05%-48.55M | -57.07%-39.78M | -62.43%-26.95M | -32.17%-12.01M | 27.60%-33.7M |
| Research and development | -28.22%8.31M | -35.33%44.03M | -40.50%32.93M | -39.88%22.46M | -47.97%11.58M | -19.35%68.08M | -14.25%55.35M | -19.09%37.37M | -7.84%22.25M | -13.17%84.42M |
| Credit Impairment Loss | 50.86%-2.3M | -50.49%-3.05M | -17.87%-6.58M | -10.90%-6.34M | 31.81%-4.68M | 68.32%-2.03M | 41.08%-5.59M | 40.34%-5.72M | 1.36%-6.87M | -829.21%-6.4M |
| Asset Impairment Loss | -81.54%17.99K | -406.55%-66.81M | -148,697.06%-6.79M | -3,872.90%-6.27M | -84.12%97.43K | -301.84%-13.19M | 97.61%-4.57K | 80.76%-157.76K | --613.48K | 55.54%-3.28M |
| Other net revenue | 152.66%367.85K | -186.89%-55.45M | -568.94%-10.9M | -1,123.43%-11.59M | -146.53%-698.6K | 126.75%63.81M | -83.63%2.32M | -75.21%1.13M | 169.03%1.5M | 39.71%28.14M |
| Fair value change income | -64.84%582.36K | -55.63%-8.19M | -231.17%-9.94M | -136.67%-7.1M | --1.66M | -193.19%-5.26M | -129.22%-3M | -156.72%-3M | ---- | -18.14%5.65M |
| Invest income | 2,907,436.51%680.95K | 85.37%9.46M | -41.89%3.85M | -50.73%3.44M | -100.00%23.42 | -71.69%5.1M | 227.27%6.62M | 720.97%6.99M | 917.92%6.26M | 337.72%18.02M |
| -Including: Investment income associates | ---- | 90.47%-454.54K | -229.53%-325.84K | -415.83%-257.27K | ---- | -7,079.94%-4.77M | ---98.88K | 103.59%81.46K | ---- | 99.62%-66.44K |
| Asset deal income | 47.32%110.06K | -99.82%127.87K | -24.78%74.01K | -864.13%-83.81K | --74.71K | 60,502.88%69.28M | 296.18%98.4K | -6.22%10.97K | ---- | -37.64%114.32K |
| Other revenue | -40.75%1.28M | 31.35%13.01M | 102.42%8.49M | 58.17%4.75M | 43.66%2.16M | -29.43%9.91M | -63.70%4.19M | -65.92%3.01M | -15.70%1.5M | -17.49%14.04M |
| Operating profit | -155.68%-52.27M | -2,642.73%-269.27M | -1,571.41%-140.96M | -363.00%-76.12M | -158.01%-20.44M | -92.35%10.59M | -92.36%9.58M | -65.42%28.94M | -45.81%35.24M | -38.31%138.44M |
| Add:Non operating Income | -82.38%12.28K | 137.94%768.86K | 144.55%689.81K | 165.80%559.7K | 203.49%69.68K | -65.44%323.12K | 229.62%282.08K | 311.10%210.57K | 27.75%22.96K | 173.78%934.98K |
| Less:Non operating expense | -80.84%142.16K | 32.22%7.29M | 47.11%5.96M | -35.16%2.29M | -58.43%742.16K | 43.55%5.52M | 23.70%4.05M | 123.46%3.53M | 575.24%1.79M | 38.91%3.84M |
| Total profit | -148.15%-52.4M | -5,210.12%-275.8M | -2,617.23%-146.24M | -403.89%-77.85M | -163.07%-21.12M | -96.02%5.4M | -95.25%5.81M | -68.82%25.62M | -48.33%33.48M | -38.94%135.53M |
| Less:Income tax cost | 1,389.45%962.55K | -868.24%-28.23M | -83.96%172.74K | -66.47%254.83K | -102.88%-74.65K | -64.10%3.68M | -94.48%1.08M | -95.32%759.89K | -75.21%2.59M | -67.21%10.24M |
| Net profit | -153.60%-53.36M | -14,476.53%-247.56M | -3,193.58%-146.41M | -414.20%-78.11M | -168.12%-21.04M | -98.63%1.72M | -95.39%4.73M | -62.31%24.86M | -43.15%30.89M | -34.32%125.29M |
| Net profit from continuing operation | -153.60%-53.36M | -14,476.53%-247.56M | -3,193.58%-146.41M | -414.20%-78.11M | -168.12%-21.04M | -98.63%1.72M | -95.39%4.73M | -62.31%24.86M | -43.15%30.89M | -34.32%125.29M |
| Less:Minority Profit | -23.83%-1.68M | -187.24%-11.94M | -385.54%-8.46M | -1,080.52%-4.84M | -948.29%-1.35M | -308.59%-4.16M | -172.76%-1.74M | -122.91%-410.02K | -87.38%159.5K | -57.45%1.99M |
| Net profit of parent company owners | -162.52%-51.68M | -4,108.20%-235.62M | -2,230.45%-137.95M | -389.95%-73.27M | -164.07%-19.69M | -95.23%5.88M | -93.54%6.48M | -60.62%25.27M | -42.09%30.73M | -33.74%123.3M |
| Earning per share | ||||||||||
| Basic earning per share | -300.00%-0.04 | -4,350.00%-0.17 | -1,100.00%-0.1 | -350.00%-0.05 | -150.00%-0.01 | -95.56%0.004 | -85.71%0.01 | -60.00%0.02 | -50.00%0.02 | -35.71%0.09 |
| Diluted earning per share | -300.00%-0.04 | -4,350.00%-0.17 | -1,100.00%-0.1 | -350.00%-0.05 | -150.00%-0.01 | -95.56%0.004 | -85.71%0.01 | -60.00%0.02 | -50.00%0.02 | -35.71%0.09 |
| Other composite income | 228.01%4.81M | -156.49%-10.09M | -165.11%-2.14M | -162.88%-6.35M | -520.12%-3.75M | 337.79%17.86M | 203.88%3.29M | 412.21%10.1M | 125.66%893.49K | 126.98%4.08M |
| Other composite income of parent company owners | 225.43%4.31M | -156.50%-9.93M | -159.67%-1.62M | -162.70%-5.82M | -402.28%-3.44M | 333.00%17.58M | 193.09%2.72M | 410.16%9.28M | 135.12%1.14M | 126.42%4.06M |
| Other composite income of minority owners | 256.09%493.17K | -155.61%-156.14K | -191.12%-517.93K | -164.85%-533.49K | -29.61%-315.96K | 1,326.99%280.77K | 333.16%568.4K | 437.45%822.64K | 0.00%-243.78K | -92.00%19.68K |
| Total composite income | -95.83%-48.55M | -1,415.57%-257.65M | -1,952.29%-148.55M | -341.58%-84.46M | -178.02%-24.79M | -84.86%19.58M | -91.94%8.02M | -44.26%34.96M | -37.49%31.78M | -26.34%129.37M |
| Total composite income of parent company owners | -104.85%-47.37M | -1,146.68%-245.56M | -1,618.10%-139.57M | -328.91%-79.09M | -172.58%-23.13M | -81.58%23.46M | -90.56%9.19M | -43.52%34.55M | -36.05%31.86M | -25.39%127.36M |
| Total composite income of minority owners | 29.16%-1.18M | -212.08%-12.1M | -664.73%-8.98M | -1,402.33%-5.37M | -1,880.23%-1.67M | -292.60%-3.88M | -154.58%-1.17M | -73.31%412.63K | -108.26%-84.28K | -59.18%2.01M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.